Neuren Pharmaceuticals
NEU.AX
#5461
Rank
ยฃ0.83 B
Marketcap
ยฃ6.43
Share price
-9.20%
Change (1 day)
-16.33%
Change (1 year)

Revenue for Neuren Pharmaceuticals (NEU.AX)

Revenue in 2023: ยฃ0.12 Billion

According to Neuren Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.12 Billion. In 2023 the company made a revenue of ยฃ0.12 Billion an increase over the revenue in the year 2022 that were of ยฃ7.85 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Neuren Pharmaceuticals from 2002 to 2023

Annual revenue

Year Revenue Change
2023ยฃ0.12 B1495.52%
2022ยฃ7.85 M
2018ยฃ7.57 M
2016N/A
2015N/A
2014N/A
2013N/A
2012N/A
2010ยฃ3.74 M5.05%
2009ยฃ3.56 M180.1%
2008ยฃ1.27 M94.39%
2007ยฃ0.65 M505.4%
2006ยฃ0.1 M-56.63%
2005ยฃ0.24 M-73.21%
2004ยฃ0.93 M-44.32%
2003ยฃ1.67 M76.36%
2002ยฃ0.94 M